Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-16 ROBINS CHAD M CEO and Chairman Sale −5,000 $46.45 $232K 1,738,680
2020-09-16 ROBINS CHAD M CEO and Chairman Sale −5,100 $47.46 $242K 1,778,580
2020-09-16 ROBINS CHAD M CEO and Chairman Sale −400 $48.26 $19K 1,778,180
2020-09-16 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −16,680 228,000
2020-09-15 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 2,000
2020-09-15 HERSHBERG ROBERT Director Sale −2,000 $42.58 $85K 0
2020-09-15 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −2,000 65,000
2020-09-15 SANG CHARLES SVP, External Affairs Option exercise +25,000 $6.32 $158K 25,000
2020-09-15 SANG CHARLES SVP, External Affairs Sale −25,000 $44.00 $1.1M 0
2020-09-15 SANG CHARLES SVP, External Affairs Option exercise · Stock Option (Right to Buy) −25,000 55,000
2020-09-15 LO FRANCIS Chief People Officer Option exercise +2,000 $7.80 $16K 2,000
2020-09-15 LO FRANCIS Chief People Officer Sale −2,000 $42.58 $85K 0
2020-09-15 LO FRANCIS Chief People Officer Option exercise · Stock Option (Right To Buy) −2,000 192,000
2020-09-14 SANG CHARLES SVP, External Affairs Option exercise +25,000 $6.55 $164K 25,000
2020-09-14 SANG CHARLES SVP, External Affairs Sale −25,000 $42.50 $1.1M 0
2020-09-14 SANG CHARLES SVP, External Affairs Option exercise · Stock Option (Right to Buy) −25,000 205,000
2020-09-11 BALDO LANCE Chief Medical Officer Option exercise +4,149 $7.80 $32K 4,149
2020-09-11 BALDO LANCE Chief Medical Officer Sale −4,149 $40.00 $166K 0
2020-09-11 BALDO LANCE Chief Medical Officer Option exercise · Stock Option (Right to Buy) −4,149 425,000
2020-09-11 Cohen Chad M Chief Financial Officer Option exercise +8,588 $6.32 $54K 9,588

Page 91 of 120 · 2,386 trades